October Pharma S.A.E Statistics
Total Valuation
EGX:OCPH has a market cap or net worth of EGP 1.29 billion. The enterprise value is 1.80 billion.
Market Cap | 1.29B |
Enterprise Value | 1.80B |
Important Dates
The next estimated earnings date is Wednesday, February 26, 2025.
Earnings Date | Feb 26, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
EGX:OCPH has 12.00 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 12.00M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -17.94% |
Owned by Insiders (%) | 0.00% |
Owned by Institutions (%) | n/a |
Float | 1.38M |
Valuation Ratios
The trailing PE ratio is 9.52.
PE Ratio | 9.52 |
Forward PE | n/a |
PS Ratio | 1.08 |
PB Ratio | 1.99 |
P/TBV Ratio | 2.28 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.26, with an EV/FCF ratio of -69.20.
EV / Earnings | 13.27 |
EV / Sales | 1.51 |
EV / EBITDA | 5.26 |
EV / EBIT | 5.62 |
EV / FCF | -69.20 |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.86.
Current Ratio | 1.58 |
Quick Ratio | 0.36 |
Debt / Equity | 0.86 |
Debt / EBITDA | 1.62 |
Debt / FCF | -21.39 |
Interest Coverage | 2.85 |
Financial Efficiency
Return on equity (ROE) is 28.01% and return on invested capital (ROIC) is 19.14%.
Return on Equity (ROE) | 28.01% |
Return on Assets (ROA) | 15.56% |
Return on Invested Capital (ROIC) | 19.14% |
Return on Capital Employed (ROCE) | 42.47% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.93 |
Inventory Turnover | 2.84 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.38% in the last 52 weeks. The beta is -0.01, so EGX:OCPH's price volatility has been lower than the market average.
Beta (5Y) | -0.01 |
52-Week Price Change | +7.38% |
50-Day Moving Average | 108.74 |
200-Day Moving Average | 106.39 |
Relative Strength Index (RSI) | 6.95 |
Average Volume (20 Days) | 1,228 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EGX:OCPH had revenue of EGP 1.19 billion and earned 135.37 million in profits. Earnings per share was 11.28.
Revenue | 1.19B |
Gross Profit | 528.83M |
Operating Income | 319.56M |
Pretax Income | 225.80M |
Net Income | 135.37M |
EBITDA | 341.40M |
EBIT | 319.56M |
Earnings Per Share (EPS) | 11.28 |
Balance Sheet
The company has 47.68 million in cash and 555.15 million in debt, giving a net cash position of -507.47 million or -42.29 per share.
Cash & Cash Equivalents | 47.68M |
Total Debt | 555.15M |
Net Cash | -507.47M |
Net Cash Per Share | -42.29 |
Equity (Book Value) | 648.62M |
Book Value Per Share | 54.05 |
Working Capital | 413.71M |
Cash Flow
In the last 12 months, operating cash flow was 23.78 million and capital expenditures -49.73 million, giving a free cash flow of -25.95 million.
Operating Cash Flow | 23.78M |
Capital Expenditures | -49.73M |
Free Cash Flow | -25.95M |
FCF Per Share | -2.16 |
Margins
Gross margin is 44.32%, with operating and profit margins of 26.78% and 13.93%.
Gross Margin | 44.32% |
Operating Margin | 26.78% |
Pretax Margin | 18.92% |
Profit Margin | 13.93% |
EBITDA Margin | 28.61% |
EBIT Margin | 26.78% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 2.33%.
Dividend Per Share | 2.50 |
Dividend Yield | 2.33% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 4 |
Payout Ratio | 33.58% |
Buyback Yield | n/a |
Shareholder Yield | 2.33% |
Earnings Yield | 10.51% |
FCF Yield | -2.01% |
Stock Splits
The last stock split was on December 7, 2022. It was a forward split with a ratio of 2.
Last Split Date | Dec 7, 2022 |
Split Type | Forward |
Split Ratio | 2 |
Scores
EGX:OCPH has an Altman Z-Score of 3.26.
Altman Z-Score | 3.26 |
Piotroski F-Score | n/a |